Actively Recruiting
Patient-therapist INTERaction During RObotic GAIT Rehabilitation After Spinal Cord Injury
Led by I.R.C.C.S. Fondazione Santa Lucia · Updated on 2024-07-31
30
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
Sponsors
I
I.R.C.C.S. Fondazione Santa Lucia
Lead Sponsor
U
University of Roma La Sapienza
Collaborating Sponsor
AI-Summary
What this Trial Is About
INTERROGAIT will disentangle the role of Physical Therapist - Patient (Pht-Pt) interaction in robotic assisted gait rehabilitation in spinal cord injury patients. The study is structured as a single blind randomized controlled trial with two arms, in which effects of different Pht-Pt interaction levels will be assessed on the ongoing robotic treatment with the Lokomat device. The main hypothesis is that when Pht-Pt interaction is maximized (experimental group), this will allow to better rehabilitation outcome with respect to a minimun level of Pht-Pt interaction (control group).
CONDITIONS
Official Title
Patient-therapist INTERaction During RObotic GAIT Rehabilitation After Spinal Cord Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Incomplete spinal cord injury lesion (ISNCSCI AIS level C or D)
- Subacute or chronic incomplete spinal cord injury
- Traumatic or non-traumatic cause of spinal cord injury
- Spinal cord injury at or above T12 level
- No severe cognitive impairment interfering with the study protocol
You will not qualify if you...
- Not meeting clinical requirements for using the Lokomat device
- Any condition preventing EEG recording
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
I.R.C.C.S. Fondazione Santa Lucia
Roma, Rome, Italy, 00179
Actively Recruiting
Research Team
F
Federica Tamburella, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here